Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. - Test2 - elhamkhani - TriplyDB

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q33709082

about

Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response Ankylosing spondylitis: A state of the art factual backbone Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations Physical activity assessment in patients with axial spondyloarthritis compared to healthy controls: a technology-based approach Endothelial dysfunction in chronic inflammatory diseases Risk of vascular events in patients with polymyalgia rheumatica.Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study Short term in-patient rehabilitation in axial spondyloarthritis - the results of a 2-week program performed in daily clinical practice Increased risk of ischemic heart disease in young patients with newly diagnosed ankylosing spondylitis--a population-based longitudinal follow-up study.Surgical arthritis service weekly rounds: ankylosing spondylitis Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study.Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis.Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation.High-density lipoproteins and the immune system Cardiorespiratory fitness and cardiovascular risk in patients with ankylosing spondylitis: a cross-sectional comparative study Predictors of Atherosclerosis in Ankylosing Spondylitis.Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients?Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease.Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights.Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?Metabolic syndrome and chronic arthritis: effects of anti-TNF-α therapy.Axial spondyloarthritis: the heart of the matter.Differences in cardiovascular manifestations between ankylosing spondylitis patients with and without kyphosis.Biologic drugs and arrhythmic risk in chronic inflammatory arthritis: the good and the bad.Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis.Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients.Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?Sex Variations in the Effects of Arthritis and Activity Limitation on First Heart Disease Event Occurrence in the Canadian General Population: Results From the Longitudinal National Population Health Survey.Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis.Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis.Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: example of etanercept in advanced ankylosing spondylitis.Evaluation of Tp-e interval and Tp-e/QT ratio in patients with ankylosing spondylitis.A nationwide population-based retrospective cohort study: increased risk of acute coronary syndrome in patients with ankylosing spondylitis.Modifiable cardiovascular risk factors in patients with ankylosing spondylitis.The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease.Acute coronary syndrome caused by infliximab in a patient with ankylosing spondylitis.Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.

P2860

Q26778275-5F804EE6-B746-472E-8640-1A8AC0FD63A1 Q26782184-37D4A185-A10C-4459-868F-7084145DEE38 Q27694518-CABE1EC9-871C-4E84-B5B2-64AB26351AAB Q28396710-051C41B7-0BFB-433C-BCFD-8DDB23FF9DEA Q34072179-30A9B649-C10E-4820-BA34-0302428BD22C Q34173514-BF51A8AF-252F-487B-9B19-97705448CE05 Q34277511-7CD560EE-8C83-4DA6-8C4A-D2F9FDE42082 Q34708922-E98471C8-59BE-44C1-975B-673030B56F46 Q34731291-FDF4D516-5A90-47B2-9CD4-20B624D8C706 Q35134554-ED324EF6-A53C-4CCB-BF5B-D3A30619A15F Q35142805-DF27E0EF-3720-4A81-B185-104E1E2076AA Q35238112-0F76953E-7098-4EBF-A2BB-75C11E7A5BD0 Q35496549-F6B0CA53-992F-4450-982F-A3275482AED0 Q36610592-2BAAFC8D-A3AB-4E96-9601-B281AF14CA8E Q36746588-09E95944-E7EF-4E07-897E-00BD97A38AC7 Q36943007-D7EBA084-4DE1-4588-92C5-535BD23E9108 Q37587350-492EA2C9-6B85-414C-A3A7-D4BE6CFA6539 Q37633533-20C5288E-0CD3-4E23-9ED5-9B218B7277CE Q38025994-58336FA5-B24A-4774-9582-E41AFB90646D Q38185646-53D38BE3-0E5C-4009-B590-4C622D3EC954 Q38271745-D8E1DDBB-7CD9-4FC9-8F64-E2DAE4155EF1 Q38469239-81DBDB97-2C7F-47DB-97D6-B24CDE056456 Q38857826-F037E63E-49F8-420B-9470-F68F66FA550B Q38898838-E814FF57-998C-4A32-9116-FEA3894F75DA Q38936667-D15C8C5B-5502-47D6-89DB-F7A6A7EF7F43 Q40405924-932F184F-B754-44A2-A0E3-A4E006CF648A Q40567109-57D1059C-E34D-4106-A28E-41D88AB49834 Q40709084-34D64390-8890-45AC-8238-E2B2F447E33D Q41210178-D0D49760-A73E-4067-9ADA-70B0018A5713 Q41456495-3E6E030D-BD31-467C-9D87-C9E9E2B00530 Q41588352-46D5304F-4DA9-4A38-94FC-CC4D01013FF2 Q41779186-43ACAB7A-1F2A-4B0D-9B73-7A7CDD434E07 Q42620841-89872029-2CB9-43D0-8B2E-20533C9C041C Q43435618-EB2106BC-B97A-4E8C-A8AC-D68E26C80E8F Q43861352-6A3206FF-9290-4C22-B3E2-211B44667B40 Q43986221-954E823C-7750-4AAE-8601-150F87A64651 Q44108141-C2706568-AF19-491F-9826-8E2C86BA9F30 Q44204800-57340434-79B4-4850-8EF5-472D5C294E52 Q45030272-437B4DF1-8A4A-4140-ABE4-F29BB1B1E7A1 Q45108856-538FDC97-15F8-49EB-A4D8-B2BAA4E1DAF5

P2860

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q33709082

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@ast

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@en

type

label

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@ast

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@en

prefLabel

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@ast

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@en

P1433

Q33709082-D367FBDD-4D84-4D4E-B18A-871E54CE1BD3

P1476

Q33709082-491B147A-56AA-48A1-9A98-7BDF91D9AF67

P2093

Q33709082-32A7DD43-B60C-4A30-9D01-2CF237C60047

P2860

Q33709082-003E8536-D9F7-40D1-9C5E-9BF7348B2CB7

Q33709082-027EA52A-BD76-431A-9C4D-AA913F4EC2C4

Q33709082-03AA1241-88FB-4AD3-AC45-97429E52D7DA

Q33709082-0D24A98B-8D8A-43DA-863B-D500CCD448B5

Q33709082-12984DC0-0BDF-47AD-A6D7-46279D5CA5F5

Q33709082-16FE0963-B452-4AF2-A402-82CEAE54B1B2

Q33709082-270B9807-245B-4C22-B106-5770EE1CBC06

Q33709082-33314F5C-18C6-4581-A811-33CA33DD601F

Q33709082-3493F206-D2DE-4AA8-B049-8222C420F1DF

Q33709082-434F8E56-1E4B-4E58-9A93-077F2FBDBF27

P304

Q33709082-1A82B0EB-35BA-4BC0-8936-A15E6D739735

P31

Q33709082-08C3C971-4F5B-454A-87B6-E91D84B3039E

Q33709082-e296ff75-edf3-443e-96c3-dcca4ed4bead

P356

Q33709082-A63F517C-31FC-4833-8B8E-59F6B1439C34

P433

Q33709082-427C292B-6E22-4033-B14D-795A68AA02A3

P478

Q33709082-E5B00988-54BE-4E73-A61A-EE6ECCD7BD09

P50

Q33709082-64E1B135-E054-4855-A242-86A3D954BDDB

Q33709082-B3A5988D-4A04-4706-8D07-881B53F2ACE9

Q33709082-D7604173-86AC-4975-93CB-DEAC67E92094

P577

Q33709082-65DAEDD8-39E6-43EC-911E-F8D1F2214693

P5875

Q33709082-FC467037-7646-4185-8D41-8A3177E71CA1

P698

Q33709082-AABA0778-0695-4659-A296-2446C279F439

P921

Q33709082-6327B62C-71C2-45DA-8001-1841DAE304DF

P356

P1433

Arthritis Care and Research

P1476

Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis.

@en

P2093

Sylvain Mathieu

http://www.w3.org/2001/XMLSchema#string

P2860

Atherosclerosis — An Inflammatory Disease

Publication bias in editorial decision making

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research

Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade.

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.

Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis.

Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases.

P304

557-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.20364

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

Martin Soubrier

Maxime Dougados

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47301456

http://www.w3.org/2001/XMLSchema#string

P698

20890982

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio